Rachel Green
Member of Scientific Advisory BoardDr. Rachel Green, Ph.D., is Member of the Scientific Advisory Board of Alltrna, Inc. and was the Chair of the Scientific Advisory Board. She served as Member of Scientific Advisory Board at Arrakis Therapeutics, Inc. since December 2023 until 2026. She has been Member of Scientific Advisory Board at Eloxx Pharmaceuticals, Inc. since May 10, 2018. Dr. Green serves as Member of Scientific Advisory Board at Moderna, Inc. (formerly known as Moderna Therapeutics, Inc.) Dr. Green is a Bloomberg Distinguished Professor, Molecular Biology and Genetics, Howard Hughes Medical Institute, Johns Hopkins University. Dr. Green’s work has focused on diverse aspects of translation and its regulation in bacteria, yeast and higher eukaryotic systems using primarily biochemistry and high throughput sequencing approaches. Recent work on mRNA surveillance mechanisms in yeast has synergized with interests in ribosome homeostasis and translational control in various tissue types. She is an elected fellow of the National Academy of Sciences (2012) and the National Academy of Medicine (2017). She consults for numerous biotech companies and serves on the scientific advisory board for Initial Therapeutics. She earned her Ph.D. in Biochemistry from Harvard Medical School, where she studied RNA and primitive self-replicating systems in Jack Szostak’s lab.
Positions
- Company NameEloxx Pharmaceuticals, Inc.Stock CodeELOXPositionMember of Scientific Advisory BoardColleagues
- SASumit AggarwalPresident, CEO & Director
- AEAlan Edmund WaltsIndependent Chairman
- DEDaniel E. GeffkenInterim Chief Financial Officer
- JWJohn WoolfordVP & Head of Corporate Development
- RCRoger ClarkVP & Head of Discovery Sciences
- TSTeji SinghVP & Head of Clinical Development
- SDSteven D. RubinIndependent Director
- DBDavid BedwellMember of Scientific Advisory Board
